Our background and experience in science enables us to find the best ideas that others may overlook. Paperboy views its portfolio companies as much more than investments in rarified invention, bur rather as long-term partnerships to protect and nurture successful businesses built on a strong foundation of protected intellectual property.
Amylin Pharmaceuticals
Aporo Biomedical
Artemis Health
BluWāv Systems
Broadband Technology Innovations
CellPoint Diagnostics
Corcept Therapeutics
CytomX, LLC
EnerTech Environmental
Green Earth Industries
Ironwood Pharmaceuticals
mNemoscience
Powerset
Rincon Pharmaceuticals
|
|
 |
|
Amylin Pharmaceuticals (NASDAQ: AMLN) discovers, develops, and markets medicines to improve the lives of people with diabetes, obesity, and cardiovascular disease. Amylin's team of world-class endocrinological researchers focuses on developing medicines from peptide hormones. Amylin recently introduced two new first-in-class drugs: Byetta (www.byetta.com) for Type 2 diabetes and Symlin (www.symlin.com) for both Type 1 and Type 2 diabetes.
www.amylin.com
|
|
|
Aporo Biomedical is a San Francisco Bay Area-based medical device company dedicated to delivering transformative closure technologies for cardiovascular and vascular therapy. The company seeks to leverage unique materials to minimally invasively facilitate healing, and then later biodegrade to leave no trace behind. The company's initial area of focus is structural heart disease, including trans-catheter treatment of patent foramen ovale (PFO) and atrial septal defect (ASD).
www.aporobiomedical.com
|
|
|
Artemis Health's mission is to provide pregnant women, their physicians and their genetic counselors with accurate, and comprehensive prenatal clinical knowledge, non-invasively and in the first trimester of pregnancy.
By replacing serum screening and significantly reducing the need for amniocentesis, the company aims to make its non-invasive prenatal screening and diagnostic tests the new standard of care for all pregnant women.
Previously known as Living MicroSystems, the company chose a new name to reflect the importance of its mission—ARTEMIS, the Olympian goddess of hunting, was the protector of pregnant women and childbirth.
www.artemishealthinc.com
|
|
|
BluWāv Systems is a recognized leader in Hybrid Drivelines, Hub Motors, Electric Propulsion, and Energy Systems for the Military, Commercial, Automotive, and Industrial markets.
www.bluwavsystems.com
|
|
|
Broadband Technology Innovations, LLC (BBTI) is an advanced communications technology company that develops and markets intellectual property. BBTI's extensive patent portfolio broadly defines xDSL systems, which when integrated with the conventional copper network of Local Exchange Carriers (LECs), enable interactive broadband services delivery to the consumer via the internet.
BBTI, the exclusive licensee of the intellectual property of Inline Connection Corporation, has the portfolio of significant patents that constitute the key enablers for ADSL systems being deployed by LECs and Internet Service Providers (ISPs). The patents cover the system of essential network elements of Splitterless ADSL.
Typical Broadband licensees will include ISPs, LECs, CLECs, and xDSL manufacturers.
www.bbtechi.com
|
|
|
CellPoint Diagnostics develops new tools for the screening, diagnosis and monitoring of cancer through the examination of bodily fluids.
www.cellpointdiagnostics.com
|
|
|
Corcept Therapeutics Incorporated (NASDAQ: CORT) is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Corcept's lead product, CORLUX, is currently in Phase III clinical trials for the treatment of the psychotic features of PMD. The drug is administered orally to PMD patients once per day for seven days. CORLUX, a potent GR-II antagonist, appears to mitigate the effects of the elevated and abnormal release patterns of cortisol seen in PMD. The Company is also conducting a proof-of-concept study evaluating the ability of CORLUX to mitigate weight gain associated with the use of olanzapine.
www.corcept.com
|
|
|
CytomX, LLC is an emerging medical technology company applying proprietary molecular engineering and microfluidic cell separation technologies to develop superior protein therapeutics and integrated medical diagnostic devices. CytomX, LLC's internal discovery and development programs build on substantial intellectual property assets and extensive technology expertise and are enhanced by strategic partnerships.
www.cytomx.com
|
|
|
EnerTech Environmental is a renewable energy company dedicated to the development and commercialization of clean combustion technologies used in treating Municipal Sewage Sludge and other high moisture wastes. The Company provides answers to the problems facing traditional waste management techniques and simultaneously creates renewable energy - all in a way that makes economic sense. EnerTec 's patented SlurryCarbTM process cleanly and economically converts these wastes into a high-grade renewable fuel, with significant cost savings over alternative management options.
www.enertech.com
|
|
|
Green Earth Industries produces fish protein hydrolysate amino acids from waste portions of filleted salmon. Markets include agriculture, animal feed, human nutrition, and pharmaceuticals.
www.geindustries.com
|
|
|
Ironwood Pharmaceuticals pursues clinical candidates with the greatest potential to make a difference in patients’ lives. Ironwood’s commitment to continually evaluate the emerging product profile and market potential of each drug candidate throughout the development process enables the company to focus its efforts on the most promising candidates.
Ironwood’s clinical programs currently include several development candidates—linaclotide, in clinical testing for irritable bowel syndrome with constipation and chronic constipation, and novel cholesterol absorption inhibitors for the treatment of high cholesterol. The company’s discovery efforts continue to produce a promising pipeline of new clinical candidates in areas such as gastrointestinal and cardiovascular diseases, pain, and inflammation.
www.ironwoodpharma.com
|
|
|
mNemoscience has developed a family of biocompatible and degradable shape-memory-polymers that has numerous applications in medicine and industry. These polymers transform their shape and other characteristics in response to temperature and other environmental changes.
mNemoscience holds a substantial set of patents that have been licensed exclusively from M.I.T., as well as many others that have been developed independently by its founders and researchers.
www.mnemoscience.com
|
|
|
Powerset is a Silicon Valley company building a transformative consumer search engine based on natural language processing. Their unique innovations in search are rooted in breakthrough technologies that take advantage of the structure and nuances of natural language. Using these advanced techniques, Powerset is building a large-scale search engine that breaks the confines of keyword search.
By making search more natural and intuitive, Powerset is fundamentally changing how we search the web, and delivering higher quality results.
www.powerset.com
|
|
|
Rincon Pharmaceuticals is a San Diego-based biopharmaceuticals company that focuses on the novel use of eukaryotic algae as a production system for recombinant proteins, especially monoclonal antibodies.
By overcoming the shortcomings inherent in current recombinant protein production technologies, Rincon aims to reduce dramatically the costs of infrastructure and protein production. The company will significantly broaden access to monoclonal antibody development and develop proprietary new products for opportunities that are uniquely enabled by the technology, both in-house and through partnerships.
www.rinconpharma.com
|
